Jade Biosciences, Inc.
JBIO
$24.71
$0.903.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 09/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 108.74% | 523.48% | -- | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 391.97% | 831.87% | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | 111.34% | 528.19% | -- | ||
|
|
|||||
| Total Current Assets | 111.34% | 528.19% | -- | ||
| Net Property, Plant & Equipment | -14.18% | 10.72% | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 15.00% | -98.58% | -- | ||
| Total Assets | 110.79% | 467.13% | -- | ||
|
|
|||||
| Total Accounts Payable | -23.11% | -8.66% | -- | ||
| Total Accrued Expenses | 45.36% | 59.78% | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 3,905.26% | -- | -- | ||
| Total Finance Division Other Current Liabilities | 174.21% | 30.61% | -- | ||
| Total Other Current Liabilities | 174.21% | 30.61% | -- | ||
| Total Current Liabilities | 46.02% | 38.90% | -- | ||
|
|
|||||
| Total Current Liabilities | 46.02% | 38.90% | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -20.71% | -13.28% | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | 43.66% | -83.57% | -- | ||
|
|
|||||
| Common Stock & APIC | 123.01% | 31,130.71% | -- | ||
| Retained Earnings | -130.66% | -152.22% | -- | ||
| Treasury Stock & Other | -2,650.00% | -- | -- | ||
| Total Common Equity | 118.26% | 455.00% | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 0.00% | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 0.00% | -- | ||
|
|
|||||
| Total Common Equity | 118.26% | 455.00% | -- | ||
| Total Preferred Equity | -- | 0.00% | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 118.26% | 455.01% | -- | ||
|
|
|||||